A. Goldman

发表

Serum lipoprotein levels during chlorthalidone therapy. A Veterans Administration-National Heart, Lung, and Blood Institute cooperative study on antihypertensive therapy: mild hypertension.

H. Perry, E. Frohlich, B. Steele, 1980, JAMA.

EVALUATION OF DRUG TREATMENT IN MILD HYPERTENSION: VA‐NHLBI FEASIBILITY TRIAL *

E. Frohlich, H. Neurath, M. Lavin, 1978, Annals of the New York Academy of Sciences.

Analysis of failure times for multiple infections following bone marrow transplantation: an application of the multiple failure time proportional hazards model.

P. Hannan, D. Weisdorf, X. Shu, 1998, Statistics in medicine.

Insights from monitoring the CPCRA didanosine/zalcitabine trial. Terry Beirn Community Programs for Clinical Research on AIDS.

D. DeMets, T. Fleming, J. Neaton, 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Four- and five-year follow-up results from four seventh-grade smoking prevention strategies

R. Luepker, P. Pirie, D. Murray, 2004, Journal of Behavioral Medicine.

Smokeless tobacco use among ninth graders in a north-central metropolitan population: cross-sectional and prospective associations with age, gender, race, family structure, and other drug use.

D. Murray, J. Whitbeck, D. Murray, 1988, Preventive medicine.

A comparative trial of didanosine or zalcitabine after treatment with zidovudine in patients with human immunodeficiency virus infection. The Terry Beirn Community Programs for Clinical Research on AIDS.

J. Neaton, N. Markowitz, R. Luskin-Hawk, 1994, The New England journal of medicine.

The cure model and time confounded risk in the analysis of survival and other timed events.

A. Goldman, 1991, Journal of clinical epidemiology.

Issues in designing sequential stopping rules for monitoring side effects in clinical trials.

A. Goldman, 1987, Controlled clinical trials.

Eventcharts: Visualizing Survival and other Timed-Events Data

Anne I. Goldman, A. Goldman, 1992 .

Response of CD4 lymphocytes and clinical consequences of treatment using ddI or ddC in patients with advanced HIV infection.

B P Carlin, B. Carlin, D. Abrams, 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Exemplary data: sample size and power in the design of event-time clinical trials.

A I Goldman, D W Hillman, D. Hillman, 1992, Controlled clinical trials.

Survivorship analysis when cure is a possibility: a Monte Carlo study.

A I Goldman, A. Goldman, 1984, Statistics in medicine.

Can dropout and other noncompliance be minimized in a clinical trial? Report from the Veterans Administrative National Heart, Lung and Blood Institute cooperative study on antihypertensive therapy: mild hypertension.

H. Perry, E. Frohlich, R. Holcomb, 1982, Controlled clinical trials.

Eventcharts: Visualizing survival and other timed event data

A. Goldman, 1989 .